Adult

Micafungin

Warning

General Information

Restricted formulary antimicrobial: For details see OUH netFormulary

Renal and hepatic impairment

Renal impairment

No dose adjustment necessary

HD/HDF/High Flux/PD - Dose as in normal renal function. Not dialysed.

 

Hepatic impairment

  • Risk of potentially life threatening hepatotoxicity
  • Use with caution in mild to moderate hepatic impairment (no dose adjustment necessary)
  • Avoid in severe hepatic impairment.

Pregnancy and breastfeeding

Discuss with pharmacy. Use only if potential benefit outweighs the risk (toxicity in animal studies) 

Additional information

Potentially life-threatening hepatotoxicity reported. Monitor liver function in all patients —discontinue if significant and persistent abnormalities in liver function tests develop.

 

References

  1. Summary of Product Characteristics (SPC) for Mycamine 100mg powder for solution for infusion. Accessed via www.medicines.org.uk 26/03/18. Last updated 05/03/18
  2. The Renal Drug Database. Micafungin. Accessed via renaldrugdatabase.com 26/03/18. Last updated 13/11/17
  3. BNF online accessed via www.medicinescomplete.com 4/1/19; last updated 11/12/18

Editorial Information

Next review date: 02 Mar 2026